From: Health impact of acute intermittent porphyria in latent and non-recurrent attacks patients
Age range | Spanish normative valuesa | SA-AIP | L-AIP | ||||
---|---|---|---|---|---|---|---|
EQ-5D-5L index | EQ-5D-5L index | N | Percentileb | EQ-5D-5L index | N | Percentileb | |
18–24 | 0.983 (0.07) | – | – | – | 1.00 (0.00) | 5 | >P95 |
25–34 | 0.977 (0.07) | 0.880 (0.10) | 4 | P5–P10 | 0.970 (0.05) | 6 | P50–P60 |
35–44 | 0.957 (0.11) | 0.808 (0.13) | 11 | P5–P10 | 0.943 (0.08) | 5 | P20–P30 |
45–54 | 0.934 (0.14) | 0.940 (0.05) | 3 | P30–P40 | 0.971 (0.06) | 5 | P50–P60 |
55–64 | 0.904 (0.17) | 0.743 (0.15) | 6 | P10–P20 | 0.796 (0.25) | 4 | P10–P20 |
65–74 | 0.870 (0.20) | 0.846 (0.09) | 2 | P10–P20 | 0.811 (0.22) | 3 | P20–P30 |
75–84 | 0.785 (0.24) | 0.342 | 1 | P5–P10 | – | – | – |